共 50 条
[31]
R&D partner selection in biopharmaceutical industry based on open innovation
[J].
ISMOT'07: Proceedings of the Fifth International Symposium on Management of Technology, Vols 1 and 2: MANAGING TOTAL INNOVATION AND OPEN INNOVATION IN THE 21ST CENTURY,
2007,
:1079-1083
[32]
Open innovation: A paradigm shift in pharma R&D?
[J].
DRUG DISCOVERY TODAY,
2022, 27 (09)
:2395-2405
[34]
Management of Outsourcing R&D in the era of open innovation
[J].
ISMOT'07: PROCEEDINGS OF THE FIFTH INTERNATIONAL SYMPOSIUM ON MANAGEMENT OF TECHNOLOGY, VOLS 1 AND 2: MANAGING TOTAL INNOVATION AND OPEN INNOVATION IN THE 21ST CENTURY,
2007,
:252-256
[35]
Networks of Interorganisational Knowledge Development Within the Open Innovation Context: The Case of R&D Intensive Start-ups
[J].
PROCEEDINGS OF THE 7TH INTERNATIONAL CONFERENCE ON INTELLECTUAL CAPITAL, KNOWLEDGE MANAGEMENT AND ORGANISATIONAL LEARNING,
2010,
:351-359
[39]
The effect of R&D tax credit on innovation: A life cycle analysis
[J].
INNOVATION-ORGANIZATION & MANAGEMENT,
2012, 14 (04)
:510-523